Cytek (CTKB) Q4 2025 Earnings Call Transcript

Motley Fool Transcribing, The Motley Fool

Fri, February 27, 2026 astatine 8:13 AM CST 29 min read

Image source: The Motley Fool.

Thursday, Feb. 26, 2026, astatine 4:30 p.m. ET

• Chief Executive Officer — Wenbin Jiang

• Chief Financial Officer — William McCombe

• Head of Investor Relations — Paul Goodson

Operator: Thank you for lasting by. My sanction is Tina, and I volition beryllium your league relation today. At this time, I would similar to invited everyone to the Cytek Biosciences, Inc. 4th fourth 2025 net call. All lines person been placed connected mute to forestall immoderate inheritance noise. After the speakers' remarks, determination volition beryllium a question-and-answer session. To retreat your question, it is present my pleasance to crook the telephone implicit to Paul Goodson, Head of Investor Relations. You whitethorn begin.

Paul Goodson: Thank you, Operator. Earlier today, Cytek Biosciences, Inc. released fiscal results for the 4th fourth and twelvemonth ended 12/31/2025. If you person not received this quality merchandise oregon you would similar to beryllium added to the company's organisation list, delight nonstop an email to [email protected]. A transcript of the quality merchandise is besides disposable connected the Investor Relations conception of the Cytek Biosciences, Inc. website astatine investors.cytekbio.com. Joining maine contiguous from Cytek Biosciences, Inc. are Wenbin Jiang, CEO, and William McCombe, CFO. Please enactment that we volition beryllium referencing a descent presumption during the telephone contiguous that has been posted to the Investors conception of our firm website.

As a reminder, connected Slide 2, we volition marque statements during the telephone that are forward-looking statements wrong the meaning of the national securities laws, including statements regarding Cytek Biosciences, Inc.'s concern plans, strategies, opportunities, and fiscal projections. These statements are based connected the company's existent expectations and inherently impact important risks and uncertainties that could origin existent results oregon events to materially disagree from those anticipated successful these statements. Additional accusation regarding these risks and uncertainties appears successful our descent presumption successful the conception entitled “Forward-Looking Statements,” successful the property merchandise Cytek Biosciences, Inc. issued today, and successful Cytek Biosciences, Inc.'s filings with the SEC.

This telephone volition besides see a treatment of definite fiscal measures that are not calculated successful accordance with mostly accepted accounting principles. Additional accusation regarding our usage of non-GAAP fiscal measures, including reconciliations to the astir straight comparable GAAP fiscal measures, whitethorn beryllium recovered successful our descent presumption and successful today's property release. While the institution believes these non-GAAP fiscal measures supply utile accusation for investors, the presumption of this accusation is not intended to beryllium considered successful isolation oregon arsenic a substitute for the fiscal accusation presented successful accordance with GAAP. Except arsenic required by law, Cytek Biosciences, Inc. disclaims immoderate work to update immoderate forward-looking statements whether due to the fact that of caller information, aboriginal events, oregon changes successful its expectations.